Concepedia

Hideaki Nagaya

HN

18

Publications

907

Citations

15

H-Index

1987

Active since

Affiliations

Takeda (Japan)(Current)

Harvard University

Hideaki Nagaya is an author at Takeda (Japan) specializing in medicine, physiology, and pharmacology.

Top concepts

Publications per year

1987–2011

18

Publications

18

In Vitro Antagonistic Properties of a New Angiotensin Type 1 Receptor Blocker, Azilsartan, in Receptor Binding and Function Studies

Mami Ojima, Hideki Igata, Masayuki Tanaka et al. · Journal of Pharmacology and Experimental Therapeutics · 2010 · 146 citations

Antisecretory and antiulcer activities of a novel proton pump inhibitor AG-1749 in dogs and rats.

Hiroshi Satoh, Nobuhiro Inatomi, Hideaki Nagaya et al. · Journal of Pharmacology and Experimental Therapeutics · 1989 · 144 citations

Possible mechanism for the inhibition of gastric (H+ + K+)-adenosine triphosphatase by the proton pump inhibitor AG-1749.

Hideaki Nagaya, Hiroya Satoh, Kentaro Kubo et al. · Journal of Pharmacology and Experimental Therapeutics · 1989 · 107 citations

Possible mechanism for the inhibition of acid formation by the proton pump inhibitor AG-1749 in isolated canine parietal cells.

Hideaki Nagaya, H Satoh, Yoshitaka Maki · Journal of Pharmacology and Experimental Therapeutics · 1990 · 93 citations

Antihypertensive, insulin-sensitising and renoprotective effects of a novel, potent and long-acting angiotensin II type 1 receptor blocker, azilsartan medoxomil, in rat and dog models

Keiji Kusumoto, Hideki Igata, Mami Ojima et al. · European Journal of Pharmacology · 2011 · 53 citations

, , +9

Rows per page

1–5 of 18